首页> 外文OA文献 >Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
【2h】

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

机译:耐多药,广泛耐药和耐泛细菌:关于获得性耐药的临时标准定义的国际专家建议

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Many different definitions for multidrug-resistant (MDR), extensively drug-resistant (XDR) and pandrug-resistant (PDR) bacteria are being used in the medical literature to characterize the different patterns of resistance found in healthcare-associated, antimicrobial-resistant bacteria. A group of international experts came together through a joint initiative by the European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC), to create a standardized international terminology with which to describe acquired resistance profiles in Staphylococcus aureus, Enterococcus spp., Enterobacteriaceae (other than Salmonella and Shigella), Pseudomonas aeruginosa and Acinetobacter spp., all bacteria often responsible for healthcare-associated infections and prone to multidrug resistance. Epidemiologically significant antimicrobial categories were constructed for each bacterium. Lists of antimicrobial categories proposed for antimicrobial susceptibility testing were created using documents and breakpoints from the Clinical Laboratory Standards Institute (CLSI), the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the United States Food and Drug Administration (FDA). MDR was defined as acquired non-susceptibility to at least one agent in three or more antimicrobial categories, XDR was defined as non-susceptibility to at least one agent in all but two or fewer antimicrobial categories (i.e. bacterial isolates remain susceptible to only one or two categories) and PDR was defined as non-susceptibility to all agents in all antimicrobial categories. To ensure correct application of these definitions, bacterial isolates should be tested against all or nearly all of the antimicrobial agents within the antimicrobial categories and selective reporting and suppression of results should be avoided.
机译:在医学文献中,对耐多药(MDR)细菌,广泛耐药(XDR)和耐泛药(PDR)细菌有许多不同的定义,以表征与医疗保健相关的抗微生物细菌中发现的不同耐药模式。一组国际专家通过欧洲疾病预防控制中心(ECDC)和疾病控制预防中心(CDC)的联合倡议聚集在一起,创建了一个标准化的国际术语,用以描述葡萄球菌的获得性耐药情况金黄色葡萄球菌,肠杆菌科细菌(沙门氏菌和志贺氏菌除外),铜绿假单胞菌和不动杆菌属,所有细菌通常与医疗保健相关,并容易产生多药耐药性。为每种细菌构建了流行病学上重要的抗菌药物类别。使用临床实验室标准协会(CLSI),欧洲抗微生物药敏试验委员会(EUCAST)和美国食品和药物管理局(FDA)的文件和断点创建了拟用于抗微生物药敏试验的抗微生物类别清单。 MDR被定义为对三种或多种抗菌剂类别中的至少一种药物不具有药敏性,XDR被定义为对除两种或两种以下抗菌剂类别中的所有药物之外的至少一种药物的不敏感性(即细菌分离株仅易感一种或多种两种类别),PDR被定义为对所有抗菌类别的所有药物均不敏感。为确保正确应用这些定义,应对细菌分离物中的所有或几乎所有抗微生物剂进行测试,并应避免选择性报告和抑制结果。
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号